As women with breast hypertrophy may have their breasts surgically reduced, the natural question is whether this operation influences their risk for breast cancer. Animal experiments have suggested that the damage to the mammary ducts caused by mammoplasty leads to the evolution of stasis and hence to cancer (Fekete and Green, 1936) . It has also been suggested, however, that surgical reduction of the breast decreases the incidence of breast cancer by reducing the number of potential foci for cancer development (Str6mbeck, 1964; Rees and Coburn, 1972) .
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This study is a second follow-up of a cohort originally studied by Lund et al. (1987) , comprising 1283 women operated on for breast hypertrophy between 1 January 1943 and 31 August 1971, who were followed up to 31 December 1982. The original study found a reduced incidence of breast cancer among these women in comparison with the Danish female population. The cohort has now been followed up to 31 December 1990.
Materials and methods
The study group consisted of all women with breast hypertrophy treated by reduction mammoplasty at five surgical departments in Copenhagen, Denmark, between 1 January 1943 and 31 August 1971, and three patients operated on before 1 January 1943. The material was collected by examining diagnostic indices and lists of operations. The hospital records of 31 patients could not be located and these patients were excluded from the analysis. In the first study five patients were included twice in the study population, which therefore consisted of 1278 women. Six patients were lost to follow-up; in our follow-up, one patient was excluded as she appeared to have died before the operation. Thus, our study group consisted of 1240 patients. Table I ).
We also looked at the risk of breast cancer on the basis of how much breast tissue was removed from the breast with the greatest reduction: <400 g, 400-600 g or >600 g. The 367 women with more than 600 g of tissue removed had a significantly lower risk than the general population (RR=0.30; 95% CI 0.10-0.69) at all time intervals after operation (latency). In addition, The aetiology of breast hypertrophy for young women (<21 years) may differ from that for older women. Young women operated on for breast hypertrophy are often slim with large breasts, whereas the older women in general tend to be obese. This difference in aetiology could explain the increased risk among young women.
As breast cancer is usually located in the upper lateral quadrant of the breast, one might expect that surgical breast reduction in which tissue was removed from this area would lead to a further reduction in the breast cancer risk. However, as in most of the types of operations tissue is removed from the middle of the breast, our data are too few to investigate this hypothesis.
The hospital records did not contain consistent information on the distribution of known risk factors for breast cancer, such as high social class (Ewertz, 1988) , nulliparity, high age at the time of first birth (Ewertz et al., 1990; Adami et al., 1990) or hormone treatment (Adami et al., 1990; Colditz et al., 1995) . We have no reason to believe, however, that the study population differs from the standard population in these respects. The missing information on the 31 patients without hospital records and for the six women lost to follow-up does not seem to relate to breast cancer risk. At the first follow-up (1983), none of the 31 patients without hospital records had breast cancer.
Some of the women operated on for breast hypertrophy were probably obese, and as obese women have an increased risk for breast cancer (Adami et al., 1990 ) the study group should have a further decreased risk compared with obese women. Obese premenopausal women, however, have a decreased risk for breast cancer, possibly because of reduced ovarian activity (Adami et al., 1990) .
No studies evaluating the risk of breast cancer for women with breast hypertrophy could be found, but Hsieh and Trichopoulos (1991) found that the size of the breast is a risk factor for breast cancer for post-menopausal women, even after correction for obesity. As our study group is characterised by large breasts, the relative risk would have been further reduced compared with women with large breasts without reduction mammoplasty. Our study population contains a preponderance of women from Copenhagen and its suburbs, where there is a slightly higher breast cancer risk than in the rest of Denmark. Hence, the expected number of cancer cases was too low (up to 15%), compared with Copenhagen women.
In conclusion, the women in this study experienced a lower risk of breast cancer than the Danish female population. The study therefore does not support the hypothesis that damage to the mammary ducts due to the operation increases the risk for cancer. On the contrary, this study indicates that reduction mammoplasty decreases the incidence of breast cancer and that the decrease is larger the more breast tissue removed.
